Recruitment And Diversity

  1. Turn AI Visibility Into Action: Build Explanation Layers For Different Stakeholders 9/4/2026

    AI visibility isn’t just about being found. Ross Jackson coaches sponsors on how to influence AI to provide clear stakeholder pathways for clinical trial involvement.

  2. Your Trial Shows Up In AI. Now What? 9/3/2026

    AI can explain your trial — but can it help patients act? Ross Jackson shares how sponsors can turn visibility into trust and next steps.

  3. Sustainable Patient Engagement: Your Enrollment And Representation Depend On It 8/21/2026

    Early and ongoing patient engagement is a crucial component to staving off recruitment trouble and securing proper patient representation. Boehringer Ingelheim's Karen Correa, Ph.D., explains how.

  4. The Art And Skill Of Caring For Terminally Ill Patients In Clinical Research And Beyond 8/14/2026

    When designing and conducting trials for terminally ill patients, Kamila Novak reminds researchers to act and speak with respect, warmth, and thoughtfulness.

  5. The Patient Advocacy Strategy Behind Skyhawk's Rapid Enrollment 8/13/2026

    Skyhawk’s patient-first approach shows how advocacy partnerships, site engagement, and operational quality can accelerate enrollment without losing focus on patients.

  6. How Visible Is Your Clinical Trial To AI? 8/3/2026

    Ross Jacksons explores how clinical trials show up — it at all — in AI tools and what that means for sponsors' approach to publicizing trial information.

  7. Why Protocol Complexity Is Slowing First Patient In — And How Small Sponsors Can Fix Start-Up Inefficiencies 7/23/2026

    Protocol complexity directly affects timelines, costs, and execution quality. Consultant Jessica Cordes explains why this challenge requires sponsors to change their approach to protocol design, feasibility, and start-up.

  8. Early Patient Education And Community Outreach Are Advancing Representation In Clinical Trials 7/16/2026

    Merck Executive Director, Clinical Trial Patient Representation, Adrelia Allen argues that patient awareness, access, early information, and trust shape are the pillars of patient representation in clinical trials.

  9. 5 Informed Consent Fixes For Sponsors And Investigators 7/14/2026

    Informed consent has never been solely about documentation, but some sponsors has treated it as a checkbox exercise. Here, consultant Tasha Mohseni shares tips and fixs for how best to approach informed consent.

  10. How One Researcher's Personal Study Experience Is Helping Him Better Serve Patients 7/6/2026

    Regeneron Executive Director in Clinical Sciences Kaniel Cassady, Ph.D., reflects on how his industry experience shaped his expectations, questions, and interactions as a patient in a clinical trial and how his patient experience is reshaping his clinical work going forward.